Abstract Background Ischemia is the major cause of acute kidney injury (AKI), associated with high mortality and morbidity. Mesenchymal stem cells (MSCs) have multilineage differentiation potential and can be a potent therapeutic option for the cure of AKI. Methods MSCs were cultured in four groups SNAP (S-nitroso N-acetyl penicillamine), SNAP + Methylene Blue (MB), MB and a control for in vitro analysis. Cultured MSCs were pre-conditioned with either SNAP (100 μM) or MB (1 μM) or both for 6 hours. Renal ischemia was induced in four groups (as in in vitro study) of rats by clamping the left renal padicle for 45 minutes and then different pre-conditioned stem cells were transplanted. Results We report that pre-conditioning of MSCs with SNAP ...
Acute kidney injury (AKI) is classically described as a rapid loss of kidney function. AKI affects m...
Backgrounds: Despite the potential therapeutic benefits, cell therapy in renal ischemia-reperfusion ...
Acute kidney injury (AKI) is classically described as a rapid loss of kidney function. AKI affects m...
Mesenchymal stem cells are renoprotective in ischemia/ reperfusion-induced acute renal failure in ra...
Mesenchymal stem cells (MSCs), discovered and isolated from the bone marrow in the 1960s and with se...
Background. Ischemia and reperfusion injury (I/R) is the major cause of acute renal failure (ARF) wi...
Mesenchymal stem cells are currently considered as a promising tool for therapeutic application in a...
Mesenchymal stem cells are currently considered as a promising tool for therapeutic application in a...
Abstract Background Acute kidney injury (AKI) is an emerging global healthcare issue without effecti...
BACKGROUNDS: Despite the potential therapeutic benefits, cell therapy in renal ischemia-reperfusion ...
Despite the potential therapeutic benefits, cell therapy in renal ischemia-reperfusion (I/R) injury ...
International audienceIschemia-reperfusion and immunosuppressive therapy are a major cause of progre...
International audienceIschemia-reperfusion and immunosuppressive therapy are a major cause of progre...
International audienceIschemia-reperfusion and immunosuppressive therapy are a major cause of progre...
Despite the potential therapeutic benefits, cell therapy in renal ischemia-reperfusion (I/R) injury ...
Acute kidney injury (AKI) is classically described as a rapid loss of kidney function. AKI affects m...
Backgrounds: Despite the potential therapeutic benefits, cell therapy in renal ischemia-reperfusion ...
Acute kidney injury (AKI) is classically described as a rapid loss of kidney function. AKI affects m...
Mesenchymal stem cells are renoprotective in ischemia/ reperfusion-induced acute renal failure in ra...
Mesenchymal stem cells (MSCs), discovered and isolated from the bone marrow in the 1960s and with se...
Background. Ischemia and reperfusion injury (I/R) is the major cause of acute renal failure (ARF) wi...
Mesenchymal stem cells are currently considered as a promising tool for therapeutic application in a...
Mesenchymal stem cells are currently considered as a promising tool for therapeutic application in a...
Abstract Background Acute kidney injury (AKI) is an emerging global healthcare issue without effecti...
BACKGROUNDS: Despite the potential therapeutic benefits, cell therapy in renal ischemia-reperfusion ...
Despite the potential therapeutic benefits, cell therapy in renal ischemia-reperfusion (I/R) injury ...
International audienceIschemia-reperfusion and immunosuppressive therapy are a major cause of progre...
International audienceIschemia-reperfusion and immunosuppressive therapy are a major cause of progre...
International audienceIschemia-reperfusion and immunosuppressive therapy are a major cause of progre...
Despite the potential therapeutic benefits, cell therapy in renal ischemia-reperfusion (I/R) injury ...
Acute kidney injury (AKI) is classically described as a rapid loss of kidney function. AKI affects m...
Backgrounds: Despite the potential therapeutic benefits, cell therapy in renal ischemia-reperfusion ...
Acute kidney injury (AKI) is classically described as a rapid loss of kidney function. AKI affects m...